$8.00
0.141.78%
Pre-Market: Sep 20, 8:00 AM EDT
15 minutes delayed
Solid Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Solid Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.61 | $-0.67 | 8.96 % |
Mar 2024 | 2024-05-15 | $-0.64 | $-0.64 | 0.00 % |
Dec 2023 | 2024-03-13 | $-1.00 | $-0.99 | -1.01 % |
Sep 2023 | 2023-11-08 | $-1.05 | $-1.19 | 11.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $0 | $1.03M | -100.0 % |
Mar 2024 | 2024-05-15 | $0 | $1.21M | -100.0 % |
Dec 2023 | 2024-03-13 | $0 | $1.10M | -100.0 % |
Sep 2023 | 2023-11-08 | $0 | $1.10M | -100.0 % |
Solid Biosciences (SLDB) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.61, which beat the estimate of $-0.67.
The Actual Revenue was $0K, which missed the estimate of $1M.
Browse earnings estimates, EPS, and revenue on all stocks.